INVESTOR RELATIONS

FINANCIAL ACTIVITIES

Check out our report section, press releases and stock details to learn more about the Health Biosciences world.

Documents and Reports

A short but detailed introduction to learn more about our data through our reports.

Consult

Press releases

Consult press releases and other information on the Holding Health Biosciences.

Consult

Stock data

By consulting the titles of Health Biosciences you will have a clear picture of our investments.

UPDATING

CORPORATE STRUCTURE

A solid holding company, made up of valuable professionals

BOARD OF DIRECTORS

NAME	POSITION	CV
Cristiano Maria Vecchietti	Chairman
Antonio Guglielmelli	Advisor
Marzia Di Vetta	Advisor

BOARD OF STATUTORY AUDITORS

NAME	POSITION
Massimo D'Agostino	Chairman
Paolo Lombardo	Auditor
Agostino Galdi	Auditor
Alessandro Zindato	Alternate Auditor
Mario Moretti	Alternate Auditor

INFORMATION FOR SHAREHOLDERS

Corporate documents

Statute

Shareholding

The share capital of Health Biosciences S.p.A. it is equal to € 5.475.985,00 represented by 10.951.970 ordinary shares. Data updated to November 13, 2020

SHAREHOLDING	NUMBER OF STOCKS	% ON SHARE CAPITAL
Health Italia	9.535.977	87,07 %
Stock market	1.415.993	12,93 %
Total	10.951.970	100 %

Significant shareholders

Anyone holding at least 5% of the share capital of Health Biosciences S.p.A. is a "Significant Shareholder".

Each shareholder has the obligation, pursuant to art. 8 of the Articles of Association, to inform the Company of the achievement or exceeding of a participation equal to 5%, 10%, 15%, 20%, 25%, 30%, 50%, 66.6%, 90% of the share capital with the right to vote, as well as to communicate any subsequent reductions, within 3 days from the date of the occurrence of such event (so-called "Substantial Change").

To this end, within 3 trading days, starting from the day on which the transaction involving the Substantial Change was carried out, the Significant Shareholder must notify Health Biosciences S.p.A .:

the identity of the significant shareholders involved;
the date when Health Biosciences S.p.A. has been informed;
the date on which the Substantial Change occurred in the investments;
the price, amount and category of financial instruments involved;
the nature of the operation;
the nature and extent of the Significant Shareholder's participation in the transaction.

The communication must be made using the attached form, sent by e-mail to investor.relator@corneliacapital.com and then sent in original by registered mail with return receipt to the administrative body at the company's registered office or via communication to the dedicated certified email address corneliainvestorrelator@legalmail.it.

Download Attachment

Investor Relator

Livia Foglia

investor.relator@corneliacapital.com

FINANCIAL ADVISOR

TAX ADVISOR

LISTING SPONSOR

Health Biosciences's Articles of Association describe the principles that govern the activity and management of the company. The Articles of Association also establish the role of the shareholders and the criteria for the appointment of the members of the Board of Directors and the Board of Statutory Auditors.

The current Articles of Association are available for consultation below.

Articles of Association

The Code of Ethics identifies the essential core of the values that make up the corporate culture and that are translated into principles and management policies as a tool for the implementation of good practices of behaviour that guide our daily actions in conducting all business activities.

The objective of the Health Biosciences Code of Ethics is to guide the management of the Group in accordance with ethical values and operating principles, in order to encourage unambiguous behavioural guidelines aimed at consolidating a positive corporate reputation.

Available soon

Health Biosciences has adopted an organisation, management and control model aimed at creating a structured and organic system of preventive control procedures and activities aimed at preventing offences, through the identification of activities exposed to the risk of offences and the consequent implementation of appropriate procedures.

The organisation, management and control model has also been adopted by subsidiaries with strategic importance.

Supervisory body

The Supervisory Body of Health Biosciences has the task of defining the organisational model of management and control for all the companies of the Group in order to prevent the responsibilities of the Company for administrative offences. The Supervisory Body also has the task of applying and analysing the information flow system that allows it to monitor the functioning of and compliance with the model, also examining the reports resulting from the audits and planning further activities.

In order to carry out its verification and control activities, the Supervisory Body has drawn up a plan of actions to verify compliance with the protocols adopted.